Febrile Neutropenia: all 147 studies
Page 2 of 2. Open to participants first (36), then studies with results posted, then the rest; newest registration first within each.
- An Observational Study to Evaluate the Safety and Efficacy of Pegfilgrastim (Neulasta®)CompletedNCT03433560
- PET/CT and Bacterial/Fungal PCR in High Risk Febrile NeutropeniaCompletedNCT03429387Not applicable
- iDTECT Blood Performance for the Identification of Viral or Bacterial Pathogens in Febrile Neutropenic PatientsStatus unknownNCT03364257
- Evaluation of Intestinal Bacterial and Fungal Translocation and Intestinal Microbiota in Febrile Neutropenic Patients in Pediatric Onco-hematologyTerminatedNCT03342365
- Anakinra: Safety and Efficacy in the Management of Fever During Neutropenia and Mucositis in ASCTCompletedNCT03233776Phase 2
- Antibiotics Management of Septic Neutropenic Patients in the Intensive Care UnitCompletedNCT03217721
- Shared Health Information System for Febrile NeutropeniaCompletedNCT03087227Not applicable
- Choosing the Best Antibiotic to Protect Friendly Gut Bacteria During the Course of Stem Cell TransplantActive, not recruitingNCT03078010Phase 2
- Early Stoppage Versus Continuation of Antimicrobial Therapy in Low Risk Pediatric Cancer Patients With Febrile Neutropenia, Before Recovery of Counts: -DALFEN StudyTerminatedNCT03003273Phase 3
- Early Antibiotic Discontinuation in FUOCompletedNCT02906254
- Shotgun Sequencing in Diagnosing Febrile Neutropenia in Patients With Acute Myeloid LeukemiaCompletedNCT02856204
- Profiling Neutrophil Counts in Patients on ChemotherapyStatus unknownNCT02806557
- The Oral Cavity as a Source of Febrile NeutropeniaCompletedNCT02702583
- Intermittent G-CSF in Patients With Breast Cancer Receiving Adjuvant Docetaxel, Doxorubicin, and Cyclophosphamide (TAC)TerminatedNCT02685111Phase 2
- Prevention of Febrile Neutropenia by Synbiotics in Pediatric Cancer PatientsStatus unknownNCT02544685Phase 2
- Multicenter Prospective Registry Study of Diffuse Large B Cell LymphomaStatus unknownNCT02474550
- Short vs Prolonged Antibiotic Treatment for Hospitalized Hemato-oncology Patients With Febrile NeutropeniaStatus unknownNCT02463747Phase 4
- Granulocyte Colony Stimulating Factor (G-CSF) After Salvage Chemotherapy in Refractory AMLStatus unknownNCT02427919Phase 2/3
- Cohort of Peripheral T Cell LymphomaStatus unknownNCT02364466
- Comparison of the Pharmacodynamics of Imipenem in Patients With Febrile NeutropeniaCompletedNCT02213783Phase 4
- Short Versus Extended Antibiotic Treatment With a Carbapenem for High-risk Febrile Neutropenia in Hematology Patients With FUOCompletedNCT02149329Phase 4
- A Phase II Study Comparing Pegylated rhG-CSF（HHPG-19K） and rhG-CSF in Breast Cancer Patients Receiving ChemotherapyCompletedNCT02119715Phase 2
- Study of Danggui Buxue Decoction in Preventing NeutropeniaCompletedNCT02005783Phase 2
- Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving ChemotherapyCompletedNCT02005458Phase 2
- A Study of Empirical Antifungal Therapy With ItraconazoleCompletedNCT01706562
- Registry of Febrile Neutropenia and Invasive Fungal InfectionsStatus unknownNCT01684189
- A Study Comparing Pegylated rhG-CSF and rhG-CSF as Support to Breast Cancer Patients Receiving ChemotherapyCompletedNCT01611051Phase 3
- Study to Reduce Duration of Antibiotic Therapy in Haematological Patients With Fever and NeutropeniaCompletedNCT01581333Phase 4
- A Study of Pegylated rhG-CSF as Support to Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy Receiving ChemotherapyStatus unknownNCT01560195Phase 3
- Short-term Antibiotic Treatment for Unexplained Fever in Solid Cancer Patients With Febrile NeutropeniaWithdrawnNCT01450241Not applicable
- Micafungin Versus Intravenous Itraconazole as Empirical Antifungal Therapy for Febrile Neutropenic Patients With Hematological DiseasesCompletedNCT01344681Phase 2
- SubCutaneous (SC) Versus Intravenous (IV) Granulocyte Colony Stimulating Factors (G-CSF) for the Treatment of Neutropenia in Hospitalized Haemato-oncological PatientsTerminatedNCT01222819Phase 4
- Value of the LightCycler® SeptiFast Test MGRADE for the Pathogen Detection in Neutropenic Hematological PatientsCompletedNCT01114165Phase 4
- Assessment of sTREM-1 as a Diagnostic Marker in Patients With Neutropenic FeverCompletedNCT01034059
- Validation of an Index of Neutropenia (D-index) in Febrile Neutropenic Cancer PatientsTerminatedNCT00982540Not applicable
- Procalcitonin Protocol to Shorten the Antibiotic Therapy in Febrile NeutropeniaCompletedNCT00928291Not applicable
- Assessment of New Blood Culture Methods on the Microbiological Documentation of Febrile NeutropeniaCompletedNCT00913042
- Diagnosis of Septicaemia by Detection of Microbial DNA in Blood in Severe InfectionsCompletedNCT00709358Phase 4
- Various G-CSF Regimens to Prevent Infection During ChemotherapyCompletedNCT00536081Phase 3
- Fatigue and Symptom Burden in Low-Risk Cancer Patients Undergoing Treatment for Febrile NeutropeniaCompletedNCT00503854
- Meropenem Versus Meropenem Plus Glycopeptide in Patients With Febrile Neutropenia After Allogenic Blood Stem Cell TransplantationCompletedNCT00462878
- Comparison of Teicoplanin and Vancomycin in Initial Empirical Antibiotic Regimen for Febrile Neutropenic PatientsCompletedNCT00454272Phase 4
- Ambisome and Management of Culture-negative Neutropenic Fever Unresponsive to AntibioticsTerminatedNCT00421187Phase 4
- Comparing Ciprofloxacin (CPFX) With Cefepime (CFPM) in Febrile Neutropenic Patients With Hematologic DiseasesCompletedNCT00137787Phase 3
- Once-Daily Amikacin Plus Cloxacillin in Febrile Neutropenic ChildrenCompletedNCT00129688Not applicable
- Safety, Tolerance and Pharmacokinetics of Anidulafungin in Immunocompromised Children Ages 2-17CompletedNCT00056381Phase 1/2
- Treatment of Neutropenic Patients With Fever Who Are Suspected to Have A Gram Positive InfectionCompletedNCT00035425Phase 3